ArticleInternational journal of chronic obstructive pulmonary disease2020
Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach.
Bhavesh Lakhotia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.